Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.

Gargaro M, Vacca C, Massari S, Scalisi G, Manni G, Mondanelli G, Mazza EMC, Bicciato S, Pallotta MT, Orabona C, Belladonna ML, Volpi C, Bianchi R, Matino D, Iacono A, Panfili E, Proietti E, Iamandii IM, Cecchetti V, Puccetti P, Tabarrini O, Fallarino F, Grohmann U.

Front Immunol. 2019 Aug 20;10:1973. doi: 10.3389/fimmu.2019.01973. eCollection 2019.

2.

Hemophilia A and B: molecular and clinical similarities and differences.

Castaman G, Matino D.

Haematologica. 2019 Sep;104(9):1702-1709. doi: 10.3324/haematol.2019.221093. Epub 2019 Aug 8. No abstract available.

3.

Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine.

Bianchini S, Orabona C, Camilloni B, Berioli MG, Argentiero A, Matino D, Alunno A, Albini E, Vacca C, Pallotta MT, Mancini G, Tascini G, Toni G, Mondanelli G, Silvestri E, Grohmann U, Esposito S.

Hum Vaccin Immunother. 2019 Aug 15:1-9. doi: 10.1080/21645515.2019.1633877. [Epub ahead of print]

PMID:
31210557
4.

Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.

Santagostino E, Riva A, Cesaro S, Esposito S, Matino D, Mazzucchelli RI, Molinari AC, Mura R, Notarangelo LD, Tagliaferri A, Di Minno G, Clerici M; the HEVA Study Group.

Haemophilia. 2019 Jul;25(4):656-667. doi: 10.1111/hae.13756. Epub 2019 Apr 16.

PMID:
30990961
5.

Amino acid metabolism as drug target in autoimmune diseases.

Mondanelli G, Iacono A, Carvalho A, Orabona C, Volpi C, Pallotta MT, Matino D, Esposito S, Grohmann U.

Autoimmun Rev. 2019 Apr;18(4):334-348. doi: 10.1016/j.autrev.2019.02.004. Epub 2019 Feb 22. Review.

6.

S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells.

Romani R, Manni G, Donati C, Pirisinu I, Bernacchioni C, Gargaro M, Pirro M, Calvitti M, Bagaglia F, Sahebkar A, Clerici G, Matino D, Pomili G, Di Renzo GC, Talesa VN, Puccetti P, Fallarino F.

Eur J Pharmacol. 2018 Aug 15;833:173-182. doi: 10.1016/j.ejphar.2018.06.005. Epub 2018 Jun 7.

7.

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.

Orabona C, Mondanelli G, Pallotta MT, Carvalho A, Albini E, Fallarino F, Vacca C, Volpi C, Belladonna ML, Berioli MG, Ceccarini G, Esposito SM, Scattoni R, Verrotti A, Ferretti A, De Giorgi G, Toni S, Cappa M, Matteoli MC, Bianchi R, Matino D, Iacono A, Puccetti M, Cunha C, Bicciato S, Antognelli C, Talesa VN, Chatenoud L, Fuchs D, Pilotte L, Van den Eynde B, Lemos MC, Romani L, Puccetti P, Grohmann U.

JCI Insight. 2018 Mar 22;3(6). pii: 96244. doi: 10.1172/jci.insight.96244.

8.

The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.

Mondanelli G, Albini E, Pallotta MT, Volpi C, Chatenoud L, Kuhn C, Fallarino F, Matino D, Belladonna ML, Bianchi R, Vacca C, Bicciato S, Boon L, Ricci G, Grohmann U, Puccetti P, Orabona C.

Front Immunol. 2017 Apr 13;8:428. doi: 10.3389/fimmu.2017.00428. eCollection 2017.

9.

CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.

Crooks J, Gargaro M, Vacca C, Volpi C, Pirro M, Scalisi G, Turco A, Romani R, Matino D, Rostami A, Puccetti P, Gran B, Fallarino F.

Mediators Inflamm. 2017;2017:1380615. doi: 10.1155/2017/1380615. Epub 2017 Mar 5.

10.

Systematic reviews of prognosis studies: a critical appraisal of five core clinical journals.

Matino D, Chai-Adisaksopha C, Iorio A.

Diagn Progn Res. 2017 Mar 16;1:9. doi: 10.1186/s41512-017-0008-z. eCollection 2017. Review.

11.

Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.

Matino D, Makris M, Dwan K, D'Amico R, Iorio A.

Cochrane Database Syst Rev. 2015 Dec 16;(12):CD004449. doi: 10.1002/14651858.CD004449.pub4. Review.

PMID:
26677005
12.

Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study.

Palareti L, Potì S, Cassis F, Emiliani F, Matino D, Iorio A.

Int J Qual Stud Health Well-being. 2015 Nov 16;10:28915. doi: 10.3402/qhw.v10.28915. eCollection 2015.

13.

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.

Matino D, Gargaro M, Santagostino E, Di Minno MN, Castaman G, Morfini M, Rocino A, Mancuso ME, Di Minno G, Coppola A, Talesa VN, Volpi C, Vacca C, Orabona C, Iannitti R, Mazzucconi MG, Santoro C, Tosti A, Chiappalupi S, Sorci G, Tagariello G, Belvini D, Radossi P, Landolfi R, Fuchs D, Boon L, Pirro M, Marchesini E, Grohmann U, Puccetti P, Iorio A, Fallarino F.

J Clin Invest. 2015 Oct 1;125(10):3766-81. doi: 10.1172/JCI81859. Epub 2015 Aug 31.

14.

Comparative proteomic analysis of two distinct stem-cell populations from human amniotic fluid.

Romani R, Fallarino F, Pirisinu I, Calvitti M, Caselli A, Fiaschi T, Gamberi T, Matino D, Talesa VN, Donti E, Puccetti P, Modesti A, Magherini F.

Mol Biosyst. 2015 Jun;11(6):1622-32. doi: 10.1039/c5mb00018a. Epub 2015 Mar 26.

PMID:
25811139
15.

Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.

Romani R, Pirisinu I, Calvitti M, Pallotta MT, Gargaro M, Bistoni G, Vacca C, Di Michele A, Orabona C, Rosati J, Pirro M, Giovagnoli S, Matino D, Prontera P, Rosi G, Grohmann U, Talesa VN, Donti E, Puccetti P, Fallarino F.

J Cell Mol Med. 2015 Jul;19(7):1593-605. doi: 10.1111/jcmm.12534. Epub 2015 Mar 17.

16.

Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR).

Nuti R, Gargaro M, Matino D, Dolciami D, Grohmann U, Puccetti P, Fallarino F, Macchiarulo A.

J Chem Inf Model. 2014 Dec 22;54(12):3373-83. doi: 10.1021/ci5005459. Epub 2014 Nov 21.

PMID:
25402742
17.

AhR-Mediated, Non-Genomic Modulation of IDO1 Function.

Pallotta MT, Fallarino F, Matino D, Macchiarulo A, Orabona C.

Front Immunol. 2014 Oct 15;5:497. doi: 10.3389/fimmu.2014.00497. eCollection 2014. Review.

18.

LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism.

Fallarino F, Pallotta MT, Matino D, Gargaro M, Orabona C, Vacca C, Mondanelli G, Allegrucci M, Boon L, Romani R, Talesa VN, Puccetti P, Grohmann U.

Immunobiology. 2015 Feb;220(2):315-21. doi: 10.1016/j.imbio.2014.09.017. Epub 2014 Sep 28.

PMID:
25278421
19.

Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward.

Matino D, Iorio A.

Haemophilia. 2014 Sep;20(5):604-6. doi: 10.1111/hae.12511. Epub 2014 Aug 25.

PMID:
25154445
20.

Aryl hydrocarbon receptor control of a disease tolerance defence pathway.

Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P.

Nature. 2014 Jul 10;511(7508):184-90. doi: 10.1038/nature13323.

21.

The haemophilia certification system in Canada.

Matino D, Teitel J, Page D, Keepanasseril A, Iorio A, Walker I.

Blood Transfus. 2014 Apr;12 Suppl 3:e531-41. doi: 10.2450/2014.0032-14s. Review. No abstract available.

22.

Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity.

Matino D, Lillicrap D, Astermark J, Dolan G, Kessler C, Lambert T, Makris M, O'Donnell J, Pipe S, Santagostino E, Saint-Remy JM, Schramm W, Iorio A.

Haemophilia. 2014 Mar;20(2):200-6. doi: 10.1111/hae.12283. Epub 2013 Oct 29.

23.

High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance.

Tagariello G, Iorio A, Matino D, Belvini D, Salviato R, Sartori R, Radossi P.

J Hematol Oncol. 2013 Aug 30;6:63. doi: 10.1186/1756-8722-6-63.

24.

Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.

Iorio A, Matino D, D'Amico R, Makris M.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD004449. doi: 10.1002/14651858.CD004449.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD004449.

PMID:
20687076

Supplemental Content

Loading ...
Support Center